Through the modulation of DR5 expression and the intervention with DR5 activators or antagonists, significant therapeutic potential has been demonstrated for treating tumors, cardiovascular diseases, autoimmune diseases, severe viral infections, and radiation injuries. The gene discussed is TNFRSF10B; the disease is viral infectious disease.